EMN vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

EMN

56.9
AI Score
VS
EMN Wins

CBT

42.6
AI Score

Investment Advisor Scores

EMN

57score
Recommendation
STRONG BUY

CBT

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EMN CBT Winner
Forward P/E 9.1996 9.9404 EMN
PEG Ratio 0.514 1.0017 EMN
Revenue Growth 9.9% 6.4% EMN
Earnings Growth 32.5% -93.7% EMN
Tradestie Score 56.9/100 42.6/100 EMN
Profit Margin 5.0% 5.2% CBT
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD EMN

Relative Price Performance (Last 90 Days)

EMN 1M: -2.2% · 3M: -4.2% CBT 1M: -5.7% · 3M: -17.5%

Current Technical Phase

EMN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.1 · Price: $65.31

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $74.33

Fundamentals Snapshot

Metric EMN CBT
Market Cap — —
Forward P/E 9.8 10.6
Trailing P/E 16.6 20.7
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 3.83 3.57
Dividend Yield 0.05% 0.02%

Frequently Asked Questions

Based on our detailed analysis, EMN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.